News
OraSure Technologies trades near cash value with minimal debt, reflecting excessive market pessimism. Read why I rate OSUR ...
MedPage Today on MSN23h
New FDA Drug Chief: 'Revolving Door' or Reformer?The founder and former CEO of several pharmaceutical companies, Tidmarsh was tapped by FDA Commissioner Marty Makary, MD, MPH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback